Loading…
Shuttle Pharmaceuticals Holdings, Inc. is projected to rise to $3.73 by 2027, a +14% move from its current price of $3.28. SHPH is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $3.05 | $3.28 | $3.53 | +0.08% |
| Jul 13 | $2.97 | $3.29 | $3.64 | +0.17% |
| Jul 14 | $2.90 | $3.29 | $3.72 | +0.25% |
| Jul 15 | $2.85 | $3.29 | $3.80 | +0.33% |
| Jul 16 | $2.80 | $3.29 | $3.87 | +0.41% |
| Jul 17 | $2.76 | $3.30 | $3.93 | +0.50% |
| Jul 18 | $2.73 | $3.30 | $3.99 | +0.58% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.73 | $3.30 | $3.99 | +0.58% |
| Week 2 | $2.54 | $3.32 | $4.34 | +1.17% |
| Week 3 | $2.40 | $3.34 | $4.64 | +1.75% |
| Week 4 | $2.29 | $3.36 | $4.91 | +2.34% |
| Week 5 | $2.21 | $3.38 | $5.17 | +2.94% |
| Week 6 | $2.13 | $3.40 | $5.41 | +3.54% |
| Week 7 | $2.06 | $3.42 | $5.65 | +4.14% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Shuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company that develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development.
The company was founded in 2012. It is headquartered in Gaithersburg, Maryland.
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is a healthcare stock trading under the SHPH ticker. The current price is $3.28.
Its market capitalization stands at $1.92M and it is ranked 5483 by market cap.
The forecast indicates a path toward higher prices over the coming years, with 2026 average at $3.28 and 2050 average at $14.35; the forecast also shows higher potential maxima, including a 2050 max of $33.00. The sentiment shifts to BULLISH in most years after 2027, with notable upside in the late 2020s through 2050.
A major floor 86.2% below — a decisive break under it would weaken the trend.
The nearest floor, 11.0% below — buyers have tended to step in here.
The nearest ceiling, 64.0% above — a clean break opens room to run.
A major ceiling 118.1% above — clearing it would confirm fresh momentum.
Key SHPH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SHPH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.31 | Sell | $3.25 | Buy |
| MA 10 | $3.40 | Sell | $3.35 | Sell |
| MA 20 | $3.63 | Sell | $3.19 | Buy |
| MA 50 | $2.00 | Buy | $2.44 | Buy |
| MA 100 | $1.46 | Buy | $2.03 | Buy |
| MA 200 | $1.94 | Buy | $4.09 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.06 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -160.44 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.17 | Sell |
| ROC (12) | -23.96 | Sell |
| Bollinger %B (20,2) | 0.00 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 3.24 | Buy |
| Awesome (5,34) | 0.71 | Buy |
| Ultimate (7,14,28) | 43.41 | Neutral |
| Momentum (10) | -0.86 | Sell |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 3.23 | Buy |
| ADX (14) | 24.64 | Sell |
| ATR (14) | 0.29 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 40. SMA50 is $5.41 and SMA200 is $15.88.
Key support is at $3.25 and resistance at $5.38; the 30-day range runs from $2.06 to $5.23. Annualized volatility is 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.92 | $3.28 | $4.59 | 0% | Neutral | |
| $2.71 | $3.73 | $5.56 | +14% | Neutral | |
| $3.45 | $5.06 | $8.03 | +54% | Bullish | |
| $3.47 | $5.36 | $8.93 | +63% | Bullish | |
| $3.30 | $5.34 | $9.27 | +63% | Bullish | |
| $2.70 | $4.56 | $8.20 | +39% | Bullish | |
| $2.36 | $4.16 | $7.70 | +27% | Bullish | |
| $2.63 | $4.83 | $9.20 | +47% | Bullish | |
| $2.48 | $4.73 | $9.24 | +44% | Bullish | |
| $3.08 | $6.11 | $12.21 | +86% | Bullish | |
| $2.33 | $5.17 | $11.34 | +58% | Bullish | |
| $6.45 | $14.32 | $32.95 | +337% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.92 | $3.28 | $3.82 | +0.00% |
| August 2026 | $2.65 | $3.21 | $4.05 | -2.11% |
| September 2026 | $2.88 | $3.54 | $4.56 | +10.16% |
| October 2026 | $2.79 | $3.47 | $4.55 | -1.97% |
| November 2026 | $2.58 | $3.24 | $4.31 | -6.47% |
| December 2026 | $2.68 | $3.40 | $4.59 | +4.95% |
Click any year to see its month-by-month SHPH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, SHPH could reach as high as $4.59, with a base case around $3.28 and support toward $2.92 — roughly 0% from $3.28. Price action looks broadly range-bound.
Expect SHPH to range from $2.71 to $5.56 through 2027. The $3.73 average target implies a +14% move from current prices. That is up +14% on the projected 2026 average. A consolidation phase looks the most probable path here.
The SHPH price prediction for 2028 points to an average of $5.06 (low $3.45, high $8.03) — a potential gain of +54% on today's $3.28. Momentum favours further upside here.
In 2029, SHPH is projected to trade between $3.47 and $8.93, averaging $5.36 — a potential gain of +63% from today's $3.28. That is up +6% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Shuttle Pharmaceuticals Holdings, Inc.'s 2030 outlook centres on $5.34, within a $3.30 to $9.27 range. That is 0% versus the projected 2029 average. That marks a +63% change versus current levels. Momentum favours further upside here.
By 2031, SHPH could reach as high as $8.20, with a base case around $4.56 and support toward $2.70 — roughly +39% from $3.28. Buyers look set to stay in control over this stretch.
Expect SHPH to range from $2.36 to $7.70 through 2032. The $4.16 average target implies a +27% move from current prices. That is -9% versus the projected 2031 average. Momentum favours further upside here.
The SHPH price prediction for 2033 points to an average of $4.83 (low $2.63, high $9.20) — a potential gain of +47% on today's $3.28. Buyers look set to stay in control over this stretch.
In 2034, SHPH is projected to trade between $2.48 and $9.24, averaging $4.73 — a potential gain of +44% from today's $3.28. That is -2% versus the projected 2033 average. Momentum favours further upside here.
Shuttle Pharmaceuticals Holdings, Inc.'s 2035 outlook centres on $6.11, within a $3.08 to $12.21 range. That is up +29% on the projected 2034 average. That marks a +86% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, SHPH could reach as high as $11.34, with a base case around $5.17 and support toward $2.33 — roughly +58% from $3.28. Momentum favours further upside here.
Expect SHPH to range from $6.45 to $32.95 through 2050. The $14.32 average target implies a +337% move from current prices. That is up +177% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in SHPH today (≈ 304.878049 SHPH) could be worth
$4,367.31
+$3,367.31 (+337%) by 2050 · US Dollar
Based on the average projected SHPH price of $14.32 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SHPHwould be worth at today's price.
$1,000 invested in SHPH on Jul 10, 2025 (≈ 235.571267 SHPH) would be worth
$772.67
-$227.33 (-22.7%) today · 0.77× · US Dollar
Based on a SHPH entry price of $4.24 vs. today's $3.28.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.58 | $916.2 | -8.4% |
| 1 month ago | $4.86 | $674.62 | -32.5% |
| 3 months ago | $0.7 | $4,685.71 | +368.6% |
| 6 months ago | $1.43 | $2,293.71 | +129.4% |
| 1 year ago | $4.24 | $772.67 | -22.7% |
| All time (3.9y) ago | $7,696 | $0.43 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SHPH forecast.
Our base-case forecast reaches $6.60 around 2050.
Implied market cap at $6.60: $3.86M
The multi-year forecast shows a bullish trajectory beginning in the late 2020s. The 2026 avg price is $3.28 and the 2027 avg is $3.72, followed by 2028 avg $5.06 and 2029 avg $5.37, with sentiment shifting to BULLISH in 2028 and 2029.
By 2030 the avg price is $5.33 with ROI 62.4%. The forecast continues with 2031 avg $4.56 and 2034 avg $4.73 as part of a bullish trend through the early 2030s.
2035 avg $6.13 with ROI 86.8%, and 2040 avg $5.17 with ROI 57.6% reflect continued upside with fluctuations. The long-range view culminates in 2050 with avg $14.35 and ROI 337.5%, and a max of $33.00.
These figures are estimates, not guarantees, and reflect a high-variance outlook typical of a micro-cap clinical-stage pharmaceutical asset.
Tap a question to reveal the answer.
In 2030 the forecasted average price is $5.33 with a min of $3.29 and a max of $9.24; ROI is 62.4% and sentiment is BULLISH.
Forecasts show bullish sentiment in multiple years (e.g., 2028, 2029, 2030, 2035, 2040, 2050) with various ROIs such as 54.3% in 2028, 63.7% in 2029, 86.8% in 2035, and 337.5% by 2050. These are estimates, not guarantees.
The forecast max values include $9.24 in 2030 and $12.24 in 2035, with $11.35 in 2040 and $33.00 in 2050.
The current price is $3.28 and the market capitalization is $1.92M.
The 30-day range is from $2.06 to $5.23.
Shuttle Pharmaceuticals Holdings, Inc. Community Discussion
0Share your Shuttle Pharmaceuticals Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.